2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Kyle A. Richards, MD, assistant professor, University of Wisconsin, discusses the association between urinary tract infections (UTI) and worse bladder cancer outcomes in the Medicare population.
Kyle A. Richards, MD, assistant professor, University of Wisconsin, discusses a retrospective analysis of the association between urinary tract infections (UTI) and worse outcomes in patients with bladder cancer from a Medicare database analysis.
A recent study used Surveillance, Epidemiology, and End Results (SEER) Medicare data to examine a cohort of patients with bladder cancer. Researchers analyzed the symptoms patients presented with and if it was a hematuria or UTI claim, as well as the time frame from symptom presentation to diagnosis.
Researchers then went forward to examine the outcomes of these patients and if they varied, based on time of diagnosis and presented symptoms, Richards explains.
Data showed that women who presented with a UTI claim had worse pathology and survival outcomes compared to women with hematuria. There was a similar association with men enrolled in the study; however, the association was greater in women.
<<<